Wednesday, Dec 17th
Last update09:36:22 AM GMT
Brand-name drugs used to treat cardiovascular disease are no better than generics, a new review of available evidence shows.
Yet a number of editorials in medical journals, written by specialists, have urged against substituting the less expensive generics for their designer counterparts.
 With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on... |
 Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico also saw an... | ||
 A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby... |
|
